1PAUL R. Comparison of Fluorine-18-2-fluorodeoxygulcose and Gallium-67 citrate imaging for detection of lymphoma[J]. J Nucl Med, 1987, 28z288--292. 被引量：1
2STUMPE K D, URBINELLI M, STEINERT H C,et al. Whole-body positron emission tomography u-sing fluorodeoxyglucose for staging of lymphoma:effectiveness and comparison with computed tomography[J]. Eur J Nucl Med, 1998, 25:721--728. 被引量：1
3FRIEDBERG J W, CHENGAZI V. PET scans in the staging of lymphoma: Current status[J]. Oncologist,2003, 8:438-447. 被引量：1
4THILL R, NEUERBURG J, FABRY U, et al. Comparison of findings with 18-FDG PET and CT in pretherapeutic staging of malignant lymphoma [ J ].Nuklearmedizin, 1997, 36:234--239. 被引量：1
6MOOG F, BANGERTER M, DIEDERICHS C G, et al. Lymphoma.Role of whole-body 2-deoxy-2-[F-18-]fluoro-D-glucose (FDG) PET in nodal staging[J].Radiology, 1997, 203:795--800. 被引量：1
7DELBEKE D, MARTIN W H, MORGAN D S, et al. 2-deoxy-2-[F-18]fluoro-D-glucose imaging with positron emission tomography for initial staging of Hodgkin's disease and lymphoma[J]. Mol Imaging Biol, 2002, 4:105--114. 被引量：1
8PARTRIDGE S, TIMOTHY A, O'DOHERTY M J,et al. 2-Fluorine-18-luoro-2-deoxy-D glucose positron emission tomography in the pretreatment stagi of Hodgkin's disease: influence on patient management in a single institution[J]. Ann Oncol, 2000,11 :1273--1279. 被引量：1
9BUCHMANN I, REINHARDT M, ELSNER K, et al, 2-(fluorine-18) fluoro-2 -deoxy-D-glucose positron emission tomography inthe detection and staging of malignant lymphoma[J]. A bicenter trial. Cancer,2001, 91.889--899. 被引量：1
10SPAEPEN K, STROOBANTS S, DUPONT P, et al. Prognostic value of positron emission tomography(PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non Hodgkin's lymphoma:Is [18F]FDG-PET a valid alternative to conventional diagnostic methods [J]? J Clin Oncol,2001, 19:414-419. 被引量：1
2Rodriguez M;Rehn S;Ahlstrom H.Predicting malignancy grade with PET in non-Hodgkin's lymphoma,1995(10). 被引量：1
3Harris NL;Jaffe ES;Diebold J.World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting-Airlie House, Virginia, November 1997[J],1999. 被引量：1
4Lapela M;Leskinen S;Minn HR.Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and 18 F-fluorodeoxyglucose,1995. 被引量：1
5Hustinx R;Benard F;Alavi A.Whole-body FDG PET imaging in the management of patients with cancer[J],2002. 被引量：1
6Jerusalem G;Beguin Y;Najjar F.Positron emission tomography (PET) with 18 F-fluorodeoxyglucose ( 18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL)[J],2001(6). 被引量：1
7Hoffmann M;Kletter K;Diemling M.Positron emission tomography with 18 F-2-fluoro-2-deoxy-D-glucose ( 18F-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type[J],1999(10). 被引量：1
